DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
企業コードDRIO
会社名DarioHealth Corp
上場日Mar 08, 2013
最高経営責任者「CEO」Raphael (Erez)
従業員数196
証券種類Ordinary Share
決算期末Mar 08
本社所在地322 W 57Th St. #33B
都市NEW YORK
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号10019
電話番号16466654667
ウェブサイトhttps://shop.mydario.com/
企業コードDRIO
上場日Mar 08, 2013
最高経営責任者「CEO」Raphael (Erez)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし